Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug
Cancer metastasis is a dynamic process during which cancer cells separate from a primary tumor, migrate through the vessel wall into the bloodstream, and extravasate at distant sites to form secondary colonies. During this process, circulating tumor cells are subjected to shear stress forces from bl...
Main Authors: | Annachiara Mitrugno, Joanna L. Sylman, Rachel A. Rigg, Samuel Tassi Yunga, Joseph J. Shatzel, Craig D. Williams, Owen J.T. McCarty |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-11-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2017.1416076 |
Similar Items
-
Artificial intelligence, platelets and aspirin
by: Giovanni de Gaetano
Published: (2024-03-01) -
Influence of Sex on Platelet Reactivity in Response to Aspirin
by: Kevin A. Friede, et al.
Published: (2020-07-01) -
The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis
by: Joanna L. Sylman, et al.
Published: (2018-03-01) -
Blood platelets, prostaglandins and aspirin: a historical and personal rereading
by: Giovanni de Gaetano, et al.
Published: (2024-03-01) -
Effect of madecassoside combined with aspirin on platelet functions
by: Theiarawat Kraikate, et al.
Published: (2015-09-01)